Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1959 Jun 15;80(12):937–943.

The Management of Idiopathic Thrombocytopenic Purpura *

Arthur A Cooperberg
PMCID: PMC1831097  PMID: 13662952

Full text

PDF
937

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DAMESHEK W., KOMNINOS Z. D. The present status of treatment of autoimmune hemolytic anemia with ACTH and cortisone. Blood. 1956 Jul;11(7):648–664. [PubMed] [Google Scholar]
  2. FALOON W. W., GREENE R. W., LOZNER E. L. The hemostatic defect in thrombocytopenia as studied by the use of ACTH and cortisone. Am J Med. 1952 Jul;13(1):12–20. doi: 10.1016/0002-9343(52)90076-4. [DOI] [PubMed] [Google Scholar]
  3. HANLON D. G. Some problems in the management and pathogenesis of idiopathic thrombocytopenic purpura. Proc Staff Meet Mayo Clin. 1952 Jul 16;27(15):273–277. [PubMed] [Google Scholar]
  4. HARRINGTON W. J., MINNICH V., HOLLINGSWORTH J. W., MOORE C. V. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951 Jul;38(1):1–10. [PubMed] [Google Scholar]
  5. HIRSCH E. O., DAMESHEK W. Idiopathic thrombocytopenia; review of eighty-nine cases with particular reference to the differentiation and treatment of acute (self-limited and chronic types). AMA Arch Intern Med. 1951 Dec;88(6):701–728. doi: 10.1001/archinte.1951.03810120002001. [DOI] [PubMed] [Google Scholar]
  6. JACOBSON B. M., SOHIER W. D. The effects of ACTH and of cortisone on the platelets in idiopathic thrombopenic purpura. N Engl J Med. 1952 Feb 14;246(7):247–249. doi: 10.1056/NEJM195202142460702. [DOI] [PubMed] [Google Scholar]
  7. MEYERS M. C., MILLER S., LINMAN J. W., BETHELL F. H. The use of ACTH and cortisone in idiopathic thrombocytopenic purpura and idiopathic acquired hemolytic anemia. Ann Intern Med. 1952 Aug;37(2):352–361. doi: 10.7326/0003-4819-37-2-352. [DOI] [PubMed] [Google Scholar]
  8. NEWTON W. A., Jr, ZUELZER W. W. Idiopathic thrombopenic purpura in childhood. N Engl J Med. 1951 Dec 6;245(23):879–885. doi: 10.1056/NEJM195112062452302. [DOI] [PubMed] [Google Scholar]
  9. ROBSON H. N., DUTHIE J. J. R. Capillary resistance and adrenocortical activity. Br Med J. 1950 Oct 28;2(4686):971–977. doi: 10.1136/bmj.2.4686.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SCHWARTZ S. O., KAPLAN S. R. Thrombocytopenic purpura: the prognostic and therapeutic value of the eosinophil index, an analysis of 100 cases. Am J Med Sci. 1950 May;219(5):528–533. doi: 10.1097/00000441-195005000-00009. [DOI] [PubMed] [Google Scholar]
  11. STEFANINI M. Management of thrombocytopenic states. AMA Arch Intern Med. 1955 Apr;95(4):543–556. doi: 10.1001/archinte.1955.00250100049005. [DOI] [PubMed] [Google Scholar]
  12. STEFANINI M., PEREZ SANTIAGO E., CHATTERJEA J. B., DAMESHEK W., SALOMON L. Corticotropin and cortisone in idiopathic thrombocytopenic purpura. J Am Med Assoc. 1952 Jun 14;149(7):647–653. doi: 10.1001/jama.1952.02930240025009. [DOI] [PubMed] [Google Scholar]
  13. WATSON-WILLIAMS E. J., MACPHERSON A. I., DAVIDSON S. The treatment of idiopathic thrombocytopenic purpura; a review of ninety-three cases. Lancet. 1958 Aug 2;2(7040):221–226. doi: 10.1016/s0140-6736(58)90057-6. [DOI] [PubMed] [Google Scholar]
  14. WILSON S. J., EISEMANN G. The effect of corticotropin (ACTH) and cortisone on idiopathic thrombocytopenic purpura. Am J Med. 1952 Jul;13(1):21–26. doi: 10.1016/0002-9343(52)90077-6. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES